Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

Enveric Biosciences IncTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.2 (market cap $6.27M), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 666.7× Enveric Biosciences Inc's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

ENVBINDV
Market Cap
$6.27M$4.18B
Volume
100,6751,819,746
Sector
HealthHealth
52-Week High
$10.80$41.83
52-Week Low
$1.27$24.09
Typical Hold Time
14 Days0 Days
Enterprise Value
-$2.03M$4.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.40, down 4.76% with a bearish technical signal from moving averages. The company shows negative profitability metrics with ROE at -235.48% and no revenue in 2025, though it has consistently beaten EPS estimates. Recent news highlights patent approvals and positive preclinical data for its neuroplastogenic therapeutics.

The outlook remains speculative given the lack of revenue and negative cash flow from operations. Analyst consensus is 75% buy, but high business execution risks and dependence on drug development success pose significant challenges for near-term shareholder value.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENVB

No sentiment data available yet.

INDV
100% Buy0% Sell
Avg holding period · 0 Days

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →